tm
Seeing Is Believing
tm
Seeing Is Believing
VIRX is currently covered by 5 analysts
Viracta Therapeutics's activity chart (see below) currently has 7 price targets and 18 ratings on display. The stock rating distribution of VIRX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 10% with an average time for these price targets to be met of 108.8 days.
Highest price target for VIRX is $3, Lowest price target is $1.
Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 05-Jan-2024. First documented stock forecast 08-Mar-2019.
Currently out of the existing stock ratings of VIRX, 13 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
2 years 8 months 10 days ago
(05-Jan-2024)
0/1 (0%)
$23.98 (217.60%)
Buy
2 years 10 months 5 days ago
(10-Nov-2023)
0/2 (0%)
$6.25 (357.14%)
Buy
2 years 10 months 5 days ago
(10-Nov-2023)
0/1 (0%)
$7.32 (273.13%)
Buy
$5
$3.93 (367.29%)
$18
3 years 1 months ago
(15-Aug-2023)
0/2 (0%)
$3.7 (284.62%)
Buy
$36
3 years 5 months 19 days ago
(27-Mar-2023)
1/2 (50%)
$20.3 (129.30%)
544
What is VIRX (Viracta Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on VIRX (Viracta Therapeutics)?
Which analyst has the current lower performing score on VIRX (Viracta Therapeutics) with a proven track record?
Which analyst has the most public recommendations on VIRX (Viracta Therapeutics)?
Which analyst is the currently most bullish on VIRX (Viracta Therapeutics)?
Which analyst is the currently most reserved on VIRX (Viracta Therapeutics)?
